लोड हो रहा है...
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose
Synthetic glucocorticoids (GCs) are widely used in the variety of dosages for treatment of premature infants with chronic lung disease, respiratory distress syndrome, allergies, asthma, and other inflammatory and autoimmune conditions. Yet, adverse effects such as glucocorticoid-induced osteoporosis...
में बचाया:
| में प्रकाशित: | Exp Biol Med (Maywood) |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publications
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363691/ https://ncbi.nlm.nih.gov/pubmed/28178857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217693322 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|